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ABSTRACT 
Complement are group of serum proteins which can be activated by antigen-antibody complexes 
or other substances, which may result in lysis of a microbial target, or a variety of other 
biological effects important in both innate and adaptive immunity. The last several years have 
seen an enormous expansion of parallel research on bacteria and the complement system and 
acquaint the role of complement proteins in biological phenomena. This study sought to find out 
the in vitro examination of bactericidal action complement proteins derived from blood sera of a 
defined group of urban and slum people against Shigella flexneri generating a critical problem in 
modern medical therapy for bacterial infections. This comparative study showed the 
susceptibility of clinical isolates of Shigella flexneri to bactericidal action of complement 
proteins of both urban and slum people blood serum. However the slum people indicated more 
effective complement mediated killing in comparison to urban people.  
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1. INTRODUCTION 
1. Background 
1.1 Shigella spp. 
Shigella are gram-negative, non-motile, facultatively anaerobic, non-sporulating, rod shaped 
bacteria that cause the disease shigellosis, which is also known as bacillary dysentery.  
Organisms of the genus Shigella belong to the Enterobacteriaceae family [Hale & Keusch, 
1996]. This group of bacteria was first described by and named after Japanese scientist Kiyoshi 
Shiga in 1898, after he isolated what he called Bacillus dysenteriae (now known to be Shigella 
dysenteriae serotype 1) from a patients’ stool during a dysentery epidemic in Japan in 1897 
[Lonnen, 2007, Thatcher, 2005]. Shigella infection is a major public health problem in 
developing countries with poor sanitation. Humans are the natural reservoir for this organism. 
Endogenous Shigella species are not present in any natural food products, but a wide variety of 
foods may be contaminated [Sureshbabu et al., 2014]. Transmission of the bacteria occurs by the 
fecal–oral route. Shigella species have a very low infective dose, as low as 10 to 100 organisms. 
Once ingested these survive gastric acidity and invade the colonic mucosa, resulting in mucosal 
abscesses and ulceration [Weir, 2002]. Destruction of the epithelial layer causes symptoms like 
watery diarrhoea, severe abdominal pain and cramping, eventuating in the bloody mucoid stool 
characteristic of bacillary dysentery. If needed treatment is not provided then shigellosis patients 
may develop secondary complications such as septicaemia and haemolytic uremic syndrome 
[Jennison & Verma, 2004]. 
1.1.1 The Four Species of Shigella spp. 
One of the major diarrheal diseases in Bangladesh, especially among children, as well as in 
several other developing countries is shigellosis [Haider et al., 1989]. It is caused by any one of 
the four species or groups of Shigella, namely, S.dysenteriae, S. flexneri, S. boydii, and S. sonnei 
[Talukdar et al., 2001]. Each of these species, with the exception of S.sonnei, is further 
subdivided into serotypes. Serotypes are defined based on the structure of exposed terminal O 
polysaccharides that form part of their outer membrane lipopolysaccharides (LPS) [Zaidi & 
Estrada-Garcia, 2014]. 
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(a) Shigella dysenteriae 
The species Shigella dysenteriae is also referred to as Group A. It has 13 serotypes [Sureshbabu 
et al., 2014]. S.dysenteriae serotype 1 is known as Shiga’s bacillus. It is indole negative and is 
the only member of the family that is always catalase negative [Parija, 2009]. It is the agent of 
epidemic shigellosis and is responsible for large-scale outbreaks in Central Africa, Southeast 
Asia, and the Indian subcontinent. In endemic areas it is isolated from up to 30% diarrheal 
patients [Hale, 1991]. Shigella dysenteriae serotype 1 is unique among Shigella species because 
it produces a potent toxin known as the Shiga toxin (Stx). Stx is a bipartite molecule composed 
of a single enzymatic A subunit and a pentamer of receptor-binding B subunits. The toxin binds 
to a glycolipid receptor found in target cells, globotriaosylceramide. It is then endocytosed 
preferentially by the clathrin-coated pathway. The A subunit is proteolytically cleaved and 
reduced, generating an A1 and an A2 peptide. The A1 peptide inhibits mammalian protein 
synthesis by cleaving the N-glycosidic bond at adenine residue 4324 in the 28S RNA of the 60S 
host cell ribosome. The importance of this toxin is that infections with Stx-producing bacteria 
may lead to hemolytic uremic syndrome (HUS), an often fatal kidney failure condition, 
particularly in children [Torres, 2004]. 
 
(b) Shigella flexneri 
Shigella flexneri is named after Flexner (1900), who described the first of the mannitol 
fermenting shigellae from Phillipines [Parija, 2009]. The species is also referred to as Group B 
and has 6 serotypes. It causes shigellosis or bacillary dysentery. S. flexneri is widespread in 
developing countries and is responsible for the worldwide endemic form of this disease 
[Sureshbabu et al., 2014]. Among the four species of Shigella, S. flexneri is the most prevalent 
species in Bangladesh [Haider et al., 1989]. This human-specific pathogen is transmitted via the 
fecal–oral route. It targets the large intestine, resulting in acute inflammation, tissue edema, and 
erosion of the colonic epithelium. The infection strategy of S. flexneri is based on:  
(i) The transfer of bacterial proteins, termed “effectors,” into targeted host cells through the 
type III secretion apparatus (T3SA), which induces the uptake of the bacteria and 
perturbs host cellular processes 
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(ii) The capacity of the intracellular bacteria to spread from cell to cell using actin 
microfilament-mediated cytoplasmic movement and reactivation of the T3SA [Arena et 
al., 2015] 
 
 
 
 
 
 
Figure 1.1: Colored scanning electron micrograph showing Shigella flexneri [CDC, 2011] 
(c) Shigella boydii 
Shigella boydii is named after Boyd, who first described these strains from India (1931) [Parija, 
2009].  The species is also referred to as Group C and has 18 serotypes [Sureshbabu et al., 2014]. 
In comparison with other Shigella serogroups this species has been less often reported 
worldwide. S.boydii is typically related with people who have travelled to endemic areas but it is 
relatively rare in developed countries. Isolation rate of this species is less than 1–2% of the total 
Shigella isolates, except in the Indian subcontinent [Ranjbar et al., 2008].  
Shigella of any species can cause serious illness among people with compromised immune 
systems. Shigellosis is characterized by watery, bloody, or mucoid diarrhea; fever; stomach 
cramps; and nausea [Bowen, n.d.]. There are many reports of outbreaks of shigellosis in which 
different kinds of foods are involved as the vehicle of transmission of Shigella spp. In fact, data 
based on public health reports indicate that food-borne Shigella infections are more common 
than waterborne infections in the United States and other industrialized countries [Islam et al., 
1993]. In 1998, an outbreak of foodborne illness occurred at Chicago due to Shigella boydii 
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CDPH (Chicago Department of Public Health) serotype 18. The suspected food vehicles were 
parsley and cilantro imported from Mexico used to prepare bean salad [Chan & Blaschek, 2005]. 
(d) Shigella sonnei 
Shigella sonnei is named after Sonne, who first described these strains from Denmark (1915) 
[Parija, 2009]. The species is also referred to as Group D and has 1 serotype [Sureshbabu et al., 
2014]. Shigella sonnei normally causes mild self-limiting infection. In recent years it has become 
the most usual Shigella species in the developed world. The spread of S.sonnei generally occurs 
in institutional or crowded settings, such as day-care centers and prisons and in military field 
settings. Shigellosis is the third leading bacterial gastrointestinal disease in the United States, 
with 25,000 cases reported in 1998 and 18,000 cases reported in 1999. Approximately 900 cases 
of S.sonnei infection are reported annually in the United Kingdom, and 15 cases of S.sonnei 
infection were reported to the National Disease Surveillance Centre in Ireland in 2001 [DeLappe 
et al., 2003].  
In most of the patients infected with S.sonnei, watery diarrhea occurs as a prodrome, or as the 
only clinical manifestation [Hale & Keusch, 1996]. However, some patients with Shigella 
infection- especially those with S.sonnei-never progress to the dysenteric phase, whereas others 
may develop dysentery without a prodrome [Bergelson et al., 2008].  
An outbreak of S.sonnei occurred in the Los Angeles County Department of Public Health (Los 
Angeles County, CA), in May 2012. It infected 43 people. Four representative isolates were 
submitted to the Centers for Disease Control and Prevention (CDC). Two of these isolates were 
obtained from asymptomatic, male employees of a bridge club and two from women in the same 
club. One of the male employees was a food handler [Karlsson et al., 2013]. 
1.2 Shigella flexneri 
1.2.1 Taxonomic Classification of S. flexneri 
S. flexneri is classified as shown in the following table: 
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Table 1.1: Taxonomic Classification of Shigella flexneri 
Domain Bacteria 
Kingdom Bacteria 
Phylum Proteobacteria 
Class Gamma proteobacteria 
Order Enterobacteriales 
Family Enterobacteriaceae 
Genus Shigella 
Species Shigella flexneri 
 
1.2.2 Characteristics and Morphology of S. flexneri 
S. flexneri, is a gram-negative bacilli, under the genus Shigella, belonging to the family 
Enterobacteriaceae. It has a cell wall containing a lipopolysaccharide (LPS) structure. LPS is 
composed of three covalently-linked domains. These are: 
(i) Lipid A, which is embedded in the outer membrane 
(ii) The central oligosaccharide core  
(iii) The O polysaccharide or O antigen (OAg), which is exposed to the bacterial surface  
In S. flexneri, the O antigen has two preferred chain lengths, a short OAg (S-OAg) of 11 to 17 
repeat units and a very long OAg (VL-OAg) of about 90 repeat units.  The O antigen also has 
additional glucose residues which changes its conformation making it more compact and short 
[Martinić et al., 2011]. 
Introduction   Page 6 
 
S. flexneri, like all other Shigella species is a short, rod-shaped bacterium, about 0.5 X 1-3µm in 
size. It is non-motile, nonsporing and noncapsulated. It grows at a temperature range of 10-40oC, 
with an optimum temperature of 37oC and pH of 7.4 [Parija, 2009]. 
The colonies of S. flexneri on nutrient agar are small, circular, convex, smooth and translucent 
[Parija, 2009]. They show moderate to heavy growth and appear to be grayish-white in color 
[Beckton, Dickinson and Company, 2006]. 
1.3 Virulence of Shigella flexneri 
1.3.1 Genetic Basis of Virulence 
Shigella flexneri, like all Shigella species, possesses a 213-kb virulence plasmid [Phalipon & 
Sansonneti, 2007]. This plasmid (pVir) contains the majority of genes involved in Shigella 
virulence. A 31-kb section of this plasmid encodes the type III secretion system (T3SS) and 
many of the secreted effector proteins [Marman et al., 2014]. The genes within this region have 
been broadly identified [Torres, 2004]. 
1.3.2 Virulence Factors 
Shigella flexneri, like all Shigella species, contains certain virulence factors. These are: 
a) The type III secretion system (T3SS): The T3SS is a needle-like structure that causes 
the translocation of Shigella effector proteins from the bacterial cytoplasm to the 
membrane and cytoplasm of the host cell. It assembles in a structure spanning both the 
inner and outer bacterial membranes and extends a 60-nm needle into the external 
environment. Contact of bacteria with host cells results in a secretion signal, upon which 
a rapid burst of protein secretion occurs [Phalipon & Sansonetti, 2007].  
 
The transcription and expression of this S. flexneri T3SS is induced by the VirF/VirB 
system when the temperature is shifted from 30°C to 37°C [Zurawski et al., 2006]. 
 
b) Effector proteins: 
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The effector proteins are secreted by the type III secretion system (T3SS) into host cells. 
They allow the bacterium to invade, multiply within the intestinal epithelium, and subvert 
cellular and immune functions during bacterial internalization [Ashida et al., 2015]. 
The Ipa (Invasion plasmid antigen) proteins:  These proteins are necessary for entry of 
S. flexneri into epithelial cell. IpaB and IpaD regulate the entry of proteins through the 
secretion system. IpaB and IpaC form a complex interacting with the epithelial cell 
membrane, which forms a pore. It is assumed that the other Ipa proteins then travel into 
the host cytoplasm through this pore. IpaC and IpaA appear to organize and manage the 
cytoskeletal rearrangements needed for direct uptake of the organism into the normally 
nonphagocytic epithelial cell. Once the Shigella containing vacuole is formed within the 
infected cell, IpaB mediates lysis of the vacuole and the bacterium is then free in the 
cytosol [Philpott et al., 2000].  
 
IpaB also causes macrophage cell death. It binds to caspase-1 in order to begin apoptosis 
and to promote the cleavage of IL-1β and IL-18 into biological active forms [Faruque, 
2012]. 
 
IcsA/VirG outer membrane protein: This protein allows the spreading of bacteria 
within the cytoplasm and dissemination into adjacent cells [Cersini et al., 1998]. 
 
Effector proteins with unknown functions: The functions of these bacterial virulence 
effectors are yet to be explained [Phalipon & Sansonetti, 2007]. 
 
c) Toxin: 
S. flexneri produces one type of enterotoxin (ShET1), while 80% of other Shigella 
produces another type of enterotoxin (ShET2) [Hui et al., 2003]. ShET1 is thought to 
cause the watery diarrhea that occurs prior to dysentery. The enterotoxin should be 
considered as an important virulence factor, since watery diarrhea occurs in all patients 
but dysentery does not [Mcvey et al., 2013]. 
 
Introduction   Page 8 
 
d) Lipopolysaccharide (LPS): 
The LPS of Shigella is composed of the hydrophobic domain (Lipid A), a core 
oligosaccharide and an O polysaccharide or O antigen. The LPS is considered as an 
important virulence factor of the bacteria due to its O antigen and Lipid A part. The O 
antigen is involved in various aspects of Shigella virulence such as serum resistance, 
invasion and intra/intercellular spread. The Lipid A part, of the LPS, induces pro-
inflammatory cytokines and chemokines and plays a part in the inflammatory damage 
and destruction of intestinal epithelium [Tang et al., 2014]. 
 
e) Acid Tolerance: 
S. flexneri has to survive in the acidic environment of the stomach and LPS plays an 
important role in its acid resistance. LPS contains O antigen. The presence of a 
polymerized S-OAg is needed for the acid resistance of S. flexneri. This property is 
enhanced if the O antigen is glucosylated. Other than that, the addition of 
phosphoethanolamine to the 1′ phosphate of lipid A increases resistance of S. flexneri to 
extreme acid conditions, provided that O antigen is produced [Martinić et al., 2011]. 
 
1.4 Pathogenesis of Shigella flexneri 
 
 
 
 
 
 
 
 
 
Figure 1.2: Cellular pathogenesis of Shigella spp. [Schroeder & Hilbi, 2008] 
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The bacterium Shigella flexneri is a causative agent of shigellosis, which is a severe infection of 
the colonic epithelium. It is primarily transmitted between hosts via the fecal-oral route to its 
infective site in the colon [Gore & Payne, 2010]. The organism enters the colonic epithelium by 
using the M cells, which are specialized epithelial cells in the follicular associated epithelium 
(FAE) that overlie lymphoid tissue [Wassef et al., 1989]. M cells allow the intact organism to 
traverse into the underlying subepithelial pocket, inhabited by macrophages. Macrophages engulf 
Shigella, but instead of successfully destroying it in the phagosome, the macrophage succumbs 
to apoptotic death [Philpott et al., 2000]. This macrophage cell death is accompanied by the 
release of the proinflammatory cytokines interleukin-1β (IL-1β) and IL-18. IL-1β signaling sets 
off the strong intestinal inflammation characteristic of shigellosis. IL-18, on the other hand, is 
involved in the generation of an effective antibacterial response. It activates natural killer (NK) 
cells and promotes the production of gamma interferon (IFN-γ), thus amplifying innate immune 
responses [Schroeder & Hilbi, 2008]. 
 
After crossing of the intestinal barrier via M cells and escape from macrophage killing, S. 
flexneri makes contact with the basolateral membrane of the epithelial cells [Gillespie & 
Hawkey, 2006]. The organism then initiates a sequence of steps to invade these cells 
[Strelkauskas et al., 2015]. It enters the cells by a micropinocytic process, which requires 
polymerization of actin at the site of entry. The bacteria lyse the phagocytic vacuole, soon after 
its entry, and travel into the cytoplasm where they replicate [Schaechter & Lederberg, 2003]. 
This access to the cytoplasm allows the invading pathogen to interact with host cell 
microfilaments [Mounier et al., 1992]. Shigella uses these actin microfilaments for making a 
polymerization actin tail behind the bacterium and propelling S. flexneri through the cytoplasm 
until it contacts the cytoplasmic membrane. The force of the contact creates a protrusion in the 
neighbouring epithelial cell, causing lysis of both membranes and release of S. flexneri into the 
neighbouring cell [Gillespie & Hawkey, 2006].  
 
The invasion of epithelial cells by Shigella activates the transcription and secretion of IL-8. IL-8 
is chemotactic for PMN cells and it assembles these cells to the infected subepithelial area, 
where they transmigrate through the epithelial lining to reach lumenal bacteria. The arrival of 
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these cells across the epithelial layer in response to Shigella disrupts the integrity of the 
epithelium allowing lumenal bacteria to cross into the sub-mucosa without the need of M cells 
[Jennison & Verma, 2004].  
 
All these processes consisting of macrophage killing, destruction of the epithelial layer and the 
massive influx of PMN cells, worsen the bacterial infection and tissue lesion. The severe tissue 
destruction caused by Shigella spp. results in an impaired adsorption of water, nutrients, and 
solutes, which might cause the watery diarrhea as well as the blood and mucus in stools 
characteristic of shigellosis [Schroeder & Hilbi, 2008]. 
 
1.5 Shigella flexneri and Shigellosis 
 
Diarrheal diseases claim the lives of at least five million children per year in developing 
countries and shigellosis or bacillary dysentery is responsible for approximately 10% of these 
deaths [Hale, 1991]. Shigella flexneri is responsible for the worldwide endemic form of this 
disease. 
 
1.5.1 Reservoir and Means of Transmission 
The main reservoir of Shigella species are human intestines [Thatcher, 2005]. Transmission of 
the organism occurs by the fecal-oral route. The 3 major ways of contracting shigellosis are: 
(i) Eating contaminated food. This mainly refers to food washed in fecally contaminated 
water or handled by a person with poor hygiene. 
(ii) Drinking contaminated water. 
(iii) Person-to-person contact [Weir, 2002]. 
 
Flies can act as carriers of Shigella species from feces to foods left uncovered. S. flexneri can 
survive in feces for 12 days at 25oC, and can be transferred by flies, resulting in contamination of 
uncontaminated food [Islam et al., 1993].  
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Other than flies, fingers, feces, food and fomites, i.e., any contaminated object such as a cutting 
board, door handle or toys, can be involved in the transfer of the pathogen [Weir, 2002]. In 
endemic areas of Bangladesh, e.g., Matlab, Teknaf, and urban Dhaka, food-borne transmission of 
shigellosis could be a mode of transmission within homes and in small communities where 
hygienic food practices and facilities for refrigerating food are lacking [Islam et al., 1993]. 
 
1.5.2 Symptoms 
Shigellosis is a severe form of bloody diarrhea which is endemic in developing countries. The 
symptoms occur within 24-48 hours of ingestion of the etiologic agent and may persist in 
untreated adults for up to 7 days. The organism may be cultivated from stools for 30 days or 
longer [Hale & Keusch, 1996]. The symptoms of shigellosis are: 
 
a) Mild diarrhea 
b) Initial copious watery diarrhea 
c) Nausea 
d) Vomiting [Nygren et al., 2013] 
e) Painful abdominal cramps 
f) Tenesmus [Zychlinsky et al., 1996] 
g) Dysentry  with frequent, small, painful, mucoid, bloody stools [Nygren et al., 2013] 
 
Shigellosis may cause some rare complications. One of these complications is bacterimia, which 
is mainly caused by S. flexneri, the most frequently encountered species in endemic zones and 
travelers [Grondin et al., 2012]. It may also result in neurologic complications, especially 
seizures, which are common in young patients. Encephalopathy can develop as well, particularly 
during infection with S. flexneri [Paradise et al., 1996]. Reactive arthritis or Reiter syndrome can 
occur too, with S. flexneri infections [Hale, 1991]. 
 
1.5.3 Diagnosis 
Shigellosis is diagnosed by conducting a stool culture and other laboratory tests. These are 
mentioned below: 
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a) Stool culture: Stool culture is the most effective method for confirming the presence of 
infecting organism, in a shigellosis patient. Freshly passed stool specimens, with blood-
tinged plugs of mucus, is obtained during acute phase of the disease. Rectal swabs may 
also be used in order to culture shigellae [Hale & Keusch, 1996], although culture from a 
stool sample may give a better yield [Agha & Goldberg, 2006]. These specimens are 
placed in buffered glycerol saline (BGS) or Cary-Blair medium [Seidlin et al., 2006], if 
transport is required. Otherwise, since Shigella spp. are fastidious organism, they should 
be handled promptly and inoculated optimally onto agar at bedside [Agha & Goldberg, 
2006]. The swabs are normally inoculated in MacConkey agar and Salmonella-Shigella 
agar to differentiate lactose fermenter and non-lactose fermenter [Seidlin et al., 2006]. 
After overnight incubation at 37oC, colorless, non-lactose-fermenting colonies are 
inoculated into tubed slants of Kligler's Iron Agar or Triple Sugar Iron Agar. In these 
differential media, Shigella species produce an alkaline slant and an acid butt with no 
bubbles of gas in the agar. This reaction gives a presumptive identification, and slide 
agglutination tests with antisera for serogroup and serotype confirm the identification 
[Hale & Keusch, 1996]. 
 
b) Fecal leukocytes: Raid and easy determination of presence or absence of leukocytes in 
the stool can be done by microscopic examination. In a study that examined the 
usefulness of fecal leukocytes in predicting the etiology of diarrhea, the presence of fecal 
leukocytes was related with a bacterial cause of acute diarrhea in 89% of cases. Patients 
infected with Shigella had fecal polymorphonuclear leukocytes in 70 to 100% of samples 
tested, with at least 10-25 cells/hpf in most of the patients [Agha & Goldberg, 2006]. 
 
c) PCR: PCR can be used to amplify the gene coding for the invasion plasmid antigen H 
(ipaH), a gene nearly exclusively derived from the four Shigella spp. in Asia. Studies 
using ipaH-based PCR have been published from several Asian countries, including 
Thailand, Bangladesh, and more recently, India. These studies suggest that ipaH can be 
detected in a large percentage of patients with diarrhoea who are culture-negative for 
Shigella [Seidlin et al., 2006]. 
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1.5.4 Treatment 
The treatment of shigellosis can be done by using oral rehydration therapy or appropriate 
antibiotics. The use of oral rehydration therapy is an effective and safe measure for the treatment 
of acute diarrhea. However, if the patient is vomiting or is in shock from severe dehydration, 
then intravenous fluid replacement is required until initial fluid and electrolyte loss are corrected 
[Hale & Keusch, 1996]. Shigellosis is generally a self-limited disease and does not need 
antibiotic therapy, except in patients with severe colitis, who are benefitted by it [Kabir et al., 
1986]. Shigella species demonstrate increased resistance to both ampicillin and trimethoprim-
sulfamethoxazole (TMP-SMX), as shown by a recent US surveillance data, which is why 
cefixime and ceftriaxone is recommended as alternative antibiotics in treatment of infections, 
caused by the bacteria [Erdman et al., 2008].  
 
Azithromycin can be used for the treatment of Shigella infections in pediatric patients, as 
suggested by AAP (American Academy of Pediatrics). Fluoroquinolones are at present 
contraindicated in children due to potential safety concerns, but they are recommended as a 
potential alternative therapy by the AAP for the treatment of Shigella infections in pediatric 
patients [Erdman et al., 2008]. 
 
1.5.5 Prevention 
The best way to prevent shigellosis is following proper hand washing and hygiene practices. 
Foodborne transmission can be reduced by ensuring proper hygiene and sanitation during 
harvesting, production, distribution and preparation of food. Infected food workers should be 
discouraged from working while ill [Morris & Potter, 2013].   
 
Waterborne outbreaks of shigellosis can be prevented by making sure that safe drinking water is 
present. Drinking water should be protected and kept well away from toilet facilities as shigella 
can survive in tap or sterilized water for as long as 4-6 weeks [Gillespie & Hawkey, 2006]. 
 
The transmission of shigellosis in community settings, such as daycare centers, can be prevented 
by providing children and child care staff with fully stocked and operational hand washing 
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stations. The children should be supervised and assisted during hand washing. Other security 
measures include elimination of water play areas and exclusion of child care workers handling 
diapers from preparing food in child care centers or in restaurants [Morris & Potter, 2013].   
 
1.6 Outbreaks 
Shigellosis is an important public health problem and outbreaks have been reported both in 
developed and developing countries. The major modes of transmission are contaminated food as 
well as contaminated fresh produce, contaminated water and person-to-person contact. 
1.6.1 S. flexneri outbreaks in USA 
1.6.1.1 S. flexneri outbreak in Michigan, 1992 
An outbreak of S. flexneri, which is a less common Shigella species in USA, occurred in 1992 in 
Michigan. The Michigan Department of Public Health (MDPH) was notified of a group of 
persons with S. flexneri infections, all of whom had eaten at different outlets of a single 
restaurant chain. This chain prepared many foods at a central kitchen and the infections were 
associated with eating tossed salad, prepared from raw vegetables, at this kitchen. Among the 46 
patients identified, 44 had eaten this tossed salad. The contamination of the salad most likely 
occurred due to handling of salad components by infected salad preparers. The use of improper 
salad preparation techniques may also be a reason for this contamination [Dunn et al., 1995]. 
1.6.1.2 S. flexneri outbreak in California, 1998 
A restaurant associated outbreak occurred in 1998, in California, involving an unusual S. flexneri 
strain. The source of the epidemic may have been two asymptomatic culture-positive employees. 
The severity of the illness in this outbreak was significant. A previously healthy 21-year-old 
male and two women, ages 45 and 73 years, respectively, were hospitalized at a cost of more 
than $61,000. Reactive arthritis was a likely symptom among three non-hospitalized case 
patients who reported subsequent joint symptoms [Trevejo et al., 1999]. 
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The inspection of this restaurant revealed several hygiene violations, including a lack of hand 
washing between tasks and inadequate hand-washing facilities [Trevejo et al., 1999]. This may 
have been a major reason resulting in contamination of the food. 
1.6.2 S. flexneri outbreak in Taiwan, 1996 
An outbreak of shigellosis occurred in a mountainous township of Nantou County in central 
Taiwan, during August through October in 1996. The infections continued to the end of the year. 
The cases, all of which identified as infections with S. flexneri serotype 2a, were widely 
distributed in villages of the township as well as two neighboring townships [Chiou et al., 2001]. 
The outbreak occurred in the Renai Township. During July and August 1996, two typhoons hit 
central Taiwan in succession and destroyed many water supply facilities in Renai Township. The 
repairing of these facilities took two months. It was therefore suggested in the study that the 
Shigella strains had been dormant in the community and that the deterioration of sanitary and 
hygiene conditions favored the spread of the organism, resulting in the outbreak [Chiou et al., 
2001]. 
1.7 Antimicrobial Resistance of Shigella flexneri: 
Antimicrobial resistance is a global problem. Antimicrobials are the most commonly prescribed 
group of drugs in general practice and in hospitals. However, the unregulated dispensing and 
production of these antimicrobials, inadequate access to effective drugs and sometimes drugs of 
questionable quality seem to be the major factors contributing to antimicrobial resistance [Faiz & 
Basher, 2011].  
Shigellosis or bacillary dysentery is a leading cause of morbidity and mortality worldwide. The 
use of appropriate antimicrobial therapy for shigellosis may reduce symptom severity and illness 
duration, and may also prevent potentially lethal complications and further disease transmission 
[Chang et al., 2011]. However, high rate of resistance to many of the first-line antimicrobial 
agents among the strains of S. flexneri have been reported from many parts of the world in recent 
years [Khaghani et al., 2014]. Tetracycline, ampicillin and co-trimoxazole, once used as first-line 
antimicrobials, are no longer effective [“Antibiotics in the management of Shigellosis”, 2004]. 
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The increased resistance to antimicrobials in the organism occurs due to the acquisition and 
dissemination of antimicrobial resistance genes by horizontal transfer. Mobile genetic elements 
such as plasmids, transposons, integrons and gene cassettes often contain these antimicrobial 
resistance genes. [Chang et al., 2011]. 
1.7.1 Emerging Trends in Resistance among S. flexneri 
The emergence and spread of antimicrobial resistance has created difficulty in the management 
of diseases like shigellosis. Over the decades, Shigella isolates resistant to multiple agents, such 
as sulphonamides, tetracycline, ampicillin, trimethoprim-sulphamethoxazole, and nalidixic acid 
have been reported from many countries, including Bangladesh [Rahman et al., 2007]. In 1973, 
S. flexneri isolates were universally susceptible to ampicillin; however, by 1979 susceptibility 
decreased to 79% in urban Bangladesh. Similarly, the susceptibility of S. flexneri to tetracycline 
dropped from 79% in 1973 to 15% in 1979. In a recent study, at least 25% of S. flexneri isolates 
were resistant to three commonly used antibiotics such as ampicillin, co-trimoxazole and 
nalidixic acid [Faiz & Basher, 2011]. Another study conducted in Bangladesh in between 2001 
and 2002 showed that the rates of resistance of Shigella isolates to ampicillin, trimethoprim-
sulphamethoxazole, and nalidixic acid have increased to more than 50%, when compared with 
the resistance patterns in between 1991 and 1992 [Rahman et al., 2007]. 
A majority of Shigella isolates from around the world, including USA, demonstrate some 
resistance to commonly used antibiotics, such as ampicillin, chloramphenicol, TMP-SMX and 
tetracycline. In developing countries, like India and China, resistance to traditional 
antimicrobials as well as fluoroquinolones (ciprofloxacin) is also increasing rapidly. In Kolkata, 
for example, resistance to fluoroquinolones, has increased up to 25% in S. flexneri isolates 
[Barrett & Stanberry, 2009].  
1.7.2 Antimicrobial Therapy 
The choice of antimicrobials for treating shigellosis has become very limited, due to the growing 
trend of antimicrobial resistance among Shigella isolates worldwide. This is the reason why 
newer antimicrobials are being tested and provided for treating this disease. In severe form of 
dysentery due to S. flexneri, where shigellae have penetrated intestinal epithelial cells in large 
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number [Gillespie & Hawkey, 2006], pivmecillinam (oral form of mecillinam), 
fluoroquinolones, azithromycin, and third-generation cephalosporins {cefixime [Rahman et al., 
2007] and ceftriaxone [Kabir et al., 1986]} are prescribed for treatment. 
Pivmecillinam is a synthetic form of penicillin used orally. It is the pivaloyloxymethyl ester of 
mecillinam, which is absorbed readily from the gastrointestinal tract. After absorption, it 
undergoes enzymatic hydrolysis by the action of non-specific esterases with liberation of 
mecillinam, which is the antimicrobially active form of the drug. The precise mode of action of 
mecillinam has not been completely explained, but it has been shown that mecillinam interferes 
with the bacterial cell wall [Dewar et al., 2013]. Pivmecillinam is currently used as an empirical 
antimicrobial therapy for shigellosis in Bangladesh with caution since resistance to it is emerging 
[Rahman et al., 2007]. 
Fluoroquinolones are antimicrobials, which work by inhibiting bacterial replication by blocking 
their DNA replication pathway [Mehta, 2011]. Fluoroquinolones, such as ciprofloxacin, are used 
for treating shigellosis, although resistance against them is increasing. In a study conducted at 
icddr,b, between January 2004 and December 2010,  it was demonstrated that, the frequency of 
resistance to ciprofloxacin, among S. flexneri strains, increased from 0.7% in 2005 to 45.5% in 
2010 [Rahman et al., 2007]. 
Azithromycin is a macrolide antibiotic which inhibits bacterial protein synthesis, quorum-
sensing and reduces the formation of biofilm [Panham et al., 2014]. It is also used in the 
treatment of shigellosis, although not that commonly in Bangladesh [Rahman et al., 2007]. 
Cephalosporins, such as cefixime, work by interfering with bacterial cell-wall synthesis and 
division. They bind to the cell wall and cause cell death [“Cefixime”, n.d.]. Ceftriaxone, which is 
another member of this family, also works in a similar way by inhibiting bacterial cell wall 
synthesis [“Ceftriaxone”, n.d.]. Cefixime and ceftriaxone both are used in the treatment of 
shigellosis. In a recent study, cefixime was found to be clinically effective in 78% of children 
with shigellosis, predominantly caused by S. flexneri [Rahman et al., 2007]. In another study 
conducted in Bangladesh, to evaluate the clinical efficacy of ceftriaxone, its effect in reducing 
Introduction   Page 18 
 
stool frequency during 6 days was found to be significant in patients infected with S. flexneri 
[Kabir et al., 1986]. 
1.8 Immunologic responses against Shigella flexneri 
Immunologic response against S. flexneri is provided by both the innate and the adaptive 
immune systems. However, Shigella, like many enteric bacterial pathogens have the ability to 
evade these host immune systems and efficiently colonize the intestinal epithelium. The innate 
immune system triggers inflammation accompanied by inflammatory cytokine secretion, 
neutrophil recruitment and massive tissue destruction, in response to Shigella invasion and 
replication within host cells. The interactions between Shigella and adaptive immune system, 
such as T and B lymphocytes, have not been thoroughly investigated due to the lack of 
appropriate animal infection models that mimic human intestinal infection [Ashida et al., 2015]. 
Shigella are gram-negative bacteria. Human serum is considered an important host defence 
mechanism against invasive diseases caused by gram negative bacteria. It has been established 
that besides natural antibodies in the serum of apparently normal human beings, there are other 
factors such as antitoxins, antiviral antibodies, opsonins and antilysins, which play a role in the 
bactericidal activity of human serum [Igumbor & Osayande, 2000]. The complement system, 
which exists in the blood, is a vital component of the immune system. The system consists of at 
least 30 proteins that orchestrate attack on pathogenic agents [Bloch et al., 2011]. It has been 
reported that complement protein is essential for killing susceptible gram-negative bacteria 
[Igumbor & Osayande, 2000]. The functions of complement are numerous but it is most well 
known for its capacity to kill pathogens by creating pores in their surface membranes. 
Complement also participates in inflammatory reactions by attracting phagocytic cells to the site 
of injury. By opsonising pathogens, complement proteins can stimulate phagocytosis, a process 
that is mediated by complement receptors on the surface of phagocytic cells [Claire et al., 2002]. 
The main barriers that control Shigella infection are neutrophils and monocytes. In response to 
inflammatory stimuli, neutrophils migrate from the circulating blood to infected tissues, where 
they efficiently bind, engulf and inactivate bacteria. In 2002, Zychlinsky and his group 
demonstrated that, in contrast to other cells, such as macrophages, neutrophils prevent the escape 
Introduction   Page 19 
 
of Shigella from phagocytic vacuoles in which the bacteria are killed. Human neutrophil elastase 
(NE) was identified as a key host defense protein, which degrades Shigella virulence factors at a 
1000-fold lower concentration than that needed to degrade other bacterial proteins [Phalipon & 
Sansonetti, 2007]. 
Monocytes arrive to the site of infection within a few hours of Shigella infection. It is known that 
efficient bacterial phagocytosis by monocytes is opsonin dependent. Complement-dependent 
opsonization of S. flexneri with human serum resulted in efficient uptake, following which 
bacteria did not escape from the phagocytic vacuole and were rapidly killed. Complement-
dependent uptake of Shigella by both monocytes and neutrophils is therefore likely to be 
important during the early stages of infection, prior to the production of specific antibody 
[Hathaway et al., 2002]. 
1.9 Objectives of the Study 
Shigellosis occurs as an endemic disease in Bangladesh, with the predominant species being S. 
flexneri. Shigellosis is transmitted via the fecal-oral route through ingestion of contaminated 
food or water or by person to person contact. The symptoms of shigellosis can range from mild 
diarrhea to severe dysentery with the passage of frequent bloody, mucoid stools, fever and 
abdominal cramps. 
 
The population of Bangladesh, which consists of different groups due to their different lifestyle, 
food habit, health condition, may all be exposed to this pathogen, Shigella flexneri, at one time or 
other. Human blood serum from these various groups has the ability of exhibiting complement 
activity against this organism. Serum is the first body defense met by pathogen when it breaks 
through and enters the skin or epithelial lining of the organs. It contains complement, which can 
exhibit bactericidal activity through the classical or alternative pathway. 
 
The objective of this study is to compare and investigate the complement activity of human 
blood serum, collected from urban and slum based population, against Shigella flexneri. The 
lifestyle of people living in urban areas and slum areas are quite different. They do not have 
similar facilities and hygiene conditions. The population living in slum areas often lacks these 
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and is therefore expected to be more exposed to the pathogen, S. flexneri. This comparative study 
will help to analyze whether the susceptibility of S. flexneri, to complement activity of human 
blood serum, is affected by this lifestyle difference in the urban and slum based population of 
Bangladesh. This type of work is rare in Bangladesh and therefore it will improve our 
understanding about the exposure of various population groups to this microorganism and their 
response against it.  
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2. MATERIALS AND METHODS 
2 Materials and Methods 
2.1 Place of Study 
The research study was carried out in the Microbiology Specialized Research Laboratory of the 
Department of Mathematics and Natural Sciences, BRAC University, Bangladesh. 
2.2 Bacterial Strain 
A strain of Shigella flexneri was obtained from the Microbiology Specialized Research 
Laboratory of the Department of Mathematics and Natural Sciences, BRAC University, 
Bangladesh. 
2.3 Identification of S.flexneri 
In order to reconfirm that the bacterial strain obtained from the Microbiology Specialized 
Research Laboratory was S. flexneri, some identification test were performed. 
2.3.1 Identification on XLD (Xylose-Lysine-Deoxycholate) Agar 
XLD agar is a selective medium for Shigella. Shigella colonies on XLD agar are transparent pink 
or smooth red with a diameter of 1 to 2 mm [“Isolation and identification of Shigella”, n.d.]. 
XLD contains sodium deoxycholate, which inhibits the growth of gram-positive microorganisms. 
It also contains xylose, which is fermented by practically all enterics except for the shigellae and 
this property enables the differentiation of Shigella species [Beckton, Dickinson and Company, 
2007].  
The procedure followed for identification on XLD agar is given below: 
1) Colonies, assumed to be of S. flexneri, were obtained from Nutrient agar plate and 
streaked onto XLD agar plate for confirmation. 
2) The inoculated XLD agar plate was incubated overnight at 37oC. 
3) The result was observed (Figure: 3.2). 
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2.3.2 Biochemical Identification 
Biochemical identification of S. flexneri was done according to the methods described in 
Microbiology: A Laboratory Manual [Cappuccino and Sherman, 2005]. The biochemical tests 
performed were indole production test, methyl-red test, Voges-Proskauer test and citrate 
utilization test. 
 
2.3.2.1 Indole Production Test 
The indole production test is based on the ability of some bacteria, which contain the enzyme 
tryptophanase, to hydrolyze tryptophan with the production of indole, pyruvic acid and 
ammonia. The test requires a medium rich in tryptophan and a reagent known as Kovac’s 
reagent, which contains butanol, HCl and p-dimethylaminobenzaldehyde. If the addition of 
Kovac’s reagent to the inoculated and incubated tryptophan rich medium, results in the formation 
of a cherry red color on its surface, then a positive test is indicated [Capuccino & Sherman, 
2005]. However, if it results in the formation of a yellow color on the surface of the medium, 
then a negative test is indicated [MacWilliams, 2009].  
 
The procedure followed for the indole production test is given below: 
1) The organism to be tested was inoculated into peptone water and incubated overnight at 
37oC.  
2) 10 drops of Kovac’s reagent was added to the inoculated medium following incubation. 
3) The result was observed and recorded (Figure: 3.3 (C)). 
 
2.3.2.2 Methyl-Red Test 
The methyl-red test is used to identify enteric bacteria based on their ability to perform mixed-
acid fermentation. If the inoculated and incubated MR-VP medium contains bacteria that ferment 
glucose by the mixed acid pathway and produce acids, such as lactic, acetic and formic acids, 
then the pH of the medium will be lowered to about 4.  The pH indicator methyl-red will turn red 
color at this pH, indicating a positive test. Nevertheless, if the inoculated bacteria ferment 
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glucose to produce non-acidic end products such as 2,3-butanediol and acetoin, then the pH of 
the medium will be increased to about 6.0. The pH indicator methyl-red will turn yellow color at 
this pH, indicating a negative test [Capuccino & Sherman, 2005]. 
The procedure followed for the methyl-red test is given below: 
1) The organism to be tested was inoculated into MR-VP medium and incubated overnight 
at 37oC.  
2) 5 drops of methyl-red indicator was added to the inoculated medium following 
incubation. 
3) The result was observed and recorded (Figure: 3.4 (C)). 
 
2.3.2.3 Voges-Proskauer Test 
The voges-proskauer test is majorly used to determine the ability of some organisms to produce 
neutral or non-acidic end products, like acetoin, from organic acids that result from glucose 
metabolism. The reagent used for this test is the Barritt’s reagent, consisting of a mixture of 
alcoholic a-napthol and 40% potassium hydroxide solution. The acetoin (acetyl methyl carbinol) 
is oxidized to a diacetyl compound in the presence of a-napthol catalyst and a guanidine group, 
which is present in the peptone of the MR-VP medium. This reaction results in the formation of a 
pink complex that gives the medium a rose color. If a deep rose color is developed in the culture 
15 minutes after addition of Barritt’s reagent, then the presence of acetoin is ensured and a 
positive result is indicated. If no color change occurs then the result is considered to be negative 
[Capuccino & Sherman, 2005]. 
 
The procedure followed for the voges-proskauer test is given below: 
1) The organism to be tested was inoculated into MR-VP medium and incubated overnight 
at 37oC.  
2) After incubation, 10 drops of Barriitt’s reagent A was added to the inoculated medium 
and the medium was shaken. 
3) Immediately 10 drops of Barritt’s reagent B was added to the medium and the medium 
was shaken. 
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4) The result was observed and recorded 15 minutes after the addition of Barritt’s reagent 
(Figure: 3.5 (C)). 
 
2.3.2.4 Citrate Utilization Test 
The citrate utilization test is used to differentiate enteric bacteria based on their ability to produce 
the enzyme citrase and use citrate as the only source of carbon. Simmon’s citrate agar is used for 
this test. Citrate is the sole source of carbon in this medium while inorganic ammonium salt is 
the sole source of nitrogen [MacWilliams, 2009]. Citrate utilizing bacteria use the citrase enzyme 
and convert citrate to oxaloacetic acid and acetate. These products are further enzymatically 
converted to produce pyruvic acid and carbon dioxide. The medium becomes alkaline during this 
reaction, since the carbon dioxide reacts with sodium and water to form sodium carbonate, which 
is an alkaline product [Capuccino & Sherman, 2005]. In addition, ammonium hydroxide is 
produced when the ammonium salts in the medium are used as the only nitrogen source. The pH 
indicator present in Simmons citrate agar is bromthymol blue, which is green at neutral pH. The 
production of these alkaline products increases the pH of the medium to above 7.6, resulting in 
color change of bromthymol blue from green to blue, which indicates a positive test 
[MacWilliams, 2009].  
The procedure followed for the citrate utilization test is given below: 
1) The organism to be tested was inoculated into Simmons citrate agar slants and incubated 
overnight at 37oC.  
2) The result was observed and recorded (Figure: 3.6 (C)). 
 
2.4 Preservation of S.flexneri 
T1N1 agar medium was used for the preservation of S. flexneri strain. The method followed for 
preparing the stock sample is given below: 
 
1) 3ml T1N1 agar medium was prepared and taken in a small vial. 
2) The vial was autoclaved at 121oC for 15 minutes and then allowed to solidify. 
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3) The T1N1 agar butt was inoculated by stabbing bacterial growth of S. flexneri from 
nutrient agar plate and then incubated at 37oC overnight. 
4) 200µl of sterile glycerol was added and the vial was sealed with parafilm and stored at 
room temperature. 
 
2.5 Serum Sample Collection 
2.5.1 Site of Collection 
The serum samples used in the study were collected from two different locations: 
(i) 50 serum samples were collected from BRAC University, Mohakhali, Dhaka. 
(ii) 50 serum samples were collected from TNT slum, Mohakhali, Dhaka. 
 
2.5.2 Procedure for Collection 
Blood samples were collected from individuals present at the two study locations, with the help 
of a trained nurse. Each individual was required to fill up a questionnaire. It contained useful 
information essential for conducting the study. 
 
 
 
 
 
 
 
 
 
Figure 2.1: The Questionnaire Form 
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Each serum sample was collected following the steps given below: 
 
 
 
 
 
 
 
 
Figure 2.2: Collection of Blood sample 
1) Blood sample, about 5ml, was collected by venipuncture procedure, with a sterile 
disposable syringe and placed into a sterile test tube. 
2) The tube was kept in a slant position, undisturbed, in an incubator and incubated at 37oC 
for 1 hour to allow blood clotting. 
3) After completion of incubation, the tube was kept at 4oC overnight in a standing position. 
4) Serum was collected from the tube using a micropipette and placed into an appropriately 
labeled sterile microcentrifuge tube. 
5) The serum containing microcentrifuge tube was centrifuged at 3000rpm for 10 minutes, 
in order to obtain pure serum. 
6) After centrifugation, the clear supernatant, which is the serum, was collected into an 
appropriately labeled sterile microcentrifuge tube. 
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Figure 2.3: Collection of serum sample after blood clotting 
2.5.3 Preservation of Collected Serum 
The collected serum samples were stored at -20oC until further use. Repeated freezing and 
thawing of the samples were avoided in order to ensure better preservation. 
2.6 Bactericidal Assay of Human Serum against S. flexneri 
The bactericidal assay of human serum against S. flexneri was carried out by modifying and 
following some steps of the method used by Bugla-Ploskonska et al. in the research paper titled 
“Killing of Gram-Negative Bacteria with Normal Human Serum and Normal Bovine Serum: Use 
of Lysozyme and Complement Proteins in the Death of Salmonella Strains O48”. The steps 
followed were: 
1) The strains were grown overnight in YP medium and then 50µl of the bacterial culture 
was transferred to 3 ml of fresh YP medium and incubated at 37oC for 1h in a water bath  
2) After incubation, the bacterial cells were centrifuged (2500Xg for 20min at 4oC) and 
suspended in physiological saline to obtain a six-fold dilution. 
3) The bacteria with serum were incubated in a water bath at 37oC. 
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4) After 0 (T0) and 180 (T3) minutes, the samples were collected, diluted and cultured on 
nutrient agar plates for 18 h at 37oC. 
5) The microorganisms were distributed by L-shaped glass after appropriate dilution prior to 
overnight incubation in 37oC. 
 The complete procedure followed for bactericidal assay of human serum against S. flexneri is as 
follows: 
1) A loop full of S. flexneri from nutrient agar plate was inoculated in 3ml of nutrient 
broth and incubated overnight at 37oC. 
2) 25µl of the overnight bacterial culture was then transferred to 1.5ml nutrient broth, 
kept in a labeled sterile microcentrifuge tube.  
3) The culture was incubated for 1 hour at 37oC.  
4) After incubation, the bacterial cells were centrifuged at 2500Xg for 20min at 4oC 
[Bugla-Ploskonska et al., 2009]. 
5) After centrifugation, the cells were suspended in physiological saline to obtain a six-
fold dilution and vortexed.  
6) 100µl of serum was taken in a labeled sterile microcentrifuge tube and diluted with 
100µl of physiological saline. The diuted serum was then vortexed. 
7) 150µl of the diluted serum was transferred into a labeled sterile microcentrifuge tube 
and mixed with 150µl of the diluted bacterial culture and vortexed. 
8) The bacteria with serum were incubated at 37oC [Bugla-Ploskonska et al., 2009]. 
9) At 0 minute and 180 minutes of incubation, the bacteria and serum sample was 
collected and cultured on nutrient agar plates using the spread plate method. The plates 
were incubated overnight at 37oC [Bugla-Ploskonska et al., 2009]. 
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10) After completion of incubation, both the plates were observed and the results were 
recorded.
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3. RESULTS 
3 Results 
3.1 Bacterial Strain 
The strain of Shigella flexneri that was obtained from the Microbiology Specialized Research 
Laboratory of the Department of Mathematics and Natural Sciences, BRAC University, 
Bangladesh, was streaked on nutrient agar.  
 
3.2 Identification of S. flexneri 
3.2.1 Identification on XLD agar 
The assumed S. flexneri colonies from nutrient agar were streaked onto XLD agar. After 
incubation, the XLD agar showed typical red-pink colonies of S. flexneri. 
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3.2.2 Biochemical Identification 
S. flexneri colonies, from nutrient agar plate, were subjected to different biochemical tests. The 
results observed and recorded were typical to that of S. flexneri, as shown in the table:  
 
Table 3.1: Typical Results of Biochemical Tests of S. flexneri 
 
Strain Indole 
Production 
Methyl Red 
(MR) 
Voges-
Proskauer (VP) 
Citrate 
Utilization 
S.flexneri Negative (-) Positive (+) Negative (-) Negative (-) 
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3.2.2.1 Indole Production Test 
 
Figure 3.3: Test tubes showing results for Indole Production Test: (A) Positive Control (B) 
Negative Control (C) S. flexneri negative on Indole Production Test 
3.2.2.2 Methyl-Red Test 
 
Figure 3.4: Test tubes showing results for Methyl Red Test: (A) Positive Control [Acharya, 
2014] (B) Negative Control [Acharya, 2014] (C) S. flexneri positive on Methyl Red Test 
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3.2.2.3 Voges-Proskauer Test 
 
Figure 3.5: Test tubes showing results for Voges-Proskauer Test: (A) Positive Control [Aryal, 
2015] (B) Negative Control [Aryal, 2015] (C) S. flexneri negative on Voges-Proskauer Test 
3.2.2.4 Citrate Utilization Test 
 
Figure 3.6: Vials showing results for Citrate Utilization Test: (A) Positive Control (B) Negative 
Control (C) S. flexneri negative on Citrate Utilization Test 
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3.3 Preservation of S.flexneri 
S. flexneri preserved on T1N1 agar medium is shown below: 
 
Figure 3.7: T1N1 agar showing growth of 
S. flexneri culture 
 
3.4 Serum sample Collection 
The pure serum, which is obtained after centrifugation and preserved at -20oC, is shown below: 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Pure serum obtained after 
centrifugation and preserved at -20oC 
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3.5 Bactericidal Assay of Human Serum against S. flexneri 
The ability of human serum, collected from urban population and slum population, to inhibit 
growth of Shigella flexneri was assessed by taking colony counts from nutrient agar plates at 0 
minute and 180 minutes. The plates displayed growth of the bacteria immediately after mixing 
with serum, at 0 minute and 3 hours after incubation with serum, at 180 minutes. The results 
from 25 representative samples are depicted in Table 3.2 and Table 3.3. 
Table 3.2: The ability of human serum collected from urban population to inhibit the 
growth of S. flexneri at 180 minutes in 25 representative samples 
Sample No. Serum Sample  Colonies of S. flexneri 
0 minute 180 minutes 
1 SU1 TNTC 0 
2 SU2 33 0 
3 SU3 TNTC 0 
4 SU4 TNTC 1 
5 SU5 TNTC 0 
6 SU6 194 1 
7 SU7 252 0 
8 SU8 206 0 
9 SU9 265 6 
10 SU10 TNTC 0 
11 SU11 TNTC 1 
Results Page 36 
 
Sample No. Serum Sample  Colonies of S. flexneri 
0 minute 180 minutes 
12 SU12 46 0 
13 SU13 TNTC 0 
14 SU14 51 1 
15 SU15 TNTC 0 
16 SU16 TNTC 0 
17 SU17 TNTC 0 
18 SU18 136 0 
19 SU19 144 0 
20 SU20 200 0 
21 SU21 224 0 
22 SU22 231 5 
23 SU23 236 0 
24 SU24 212 0 
25 SU25 279 3 
 
The following figures display the growth of S. flexneri at 0 minute and 180 minutes in 10 
representative serum samples collected from urban area. 
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Figure 3.9: Colonies of S. flexneri on nutrient agar at 0 minute and 180 minutes with different 
serum samples collected from urban population: (A) SU1 (B) SU2(C) SU3 (D) SU4 (E) SU5 (F) 
SU6 (G) SU7 (H) SU8 (I) SU9 (J) SU10 
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The following figure is a graphical representation of serum activity against S. flexneri in 10 
representative samples of the urban population. 
 
Figure 3.10: Graphical representation of serum activity against S. flexneri at 0 minute and 180 
minutes in urban population 
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Table 3.3: The ability of human serum collected from slum population to inhibit the growth 
of S. flexneri at 180 minutes in 25 representative samples 
Sample No. Serum Sample Colonies of S. flexneri 
0 minute 180 minutes 
1 SS1 94 0 
2 SS2 6 0 
3 SS3 23 0 
4 SS4 69 0 
5 SS5 111 0 
6 SS6 68 0 
7 SS7 205 0 
8 SS8 227 0 
9 SS9 95 0 
10 SS10 63 0 
11 SS11 252 9 
12 SS12 47 31 
13 SS13 TNTC 0 
14 SS14 1 0 
15 SS15 46 1 
16 SS16 39 0 
17 SS17 130 27 
18 SS18 44 0 
19 SS19 10 0 
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Sample No. Sample Name Colonies of S. flexneri 
0 minute 180 minutes 
20 SS20 85 0 
21 SS21 1 0 
22 SS22 138 0 
23 SS23 173 0 
24 SS24 5 0 
25 SS25 193 0 
 
The following figures display the growth of S. flexneri at 0 minute and 180 minutes in 10 
representative serum samples collected from slum area. 
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Figure 3.11: Colonies of S. flexneri on nutrient agar at 0 minute and 180 minutes with different 
serum samples collected from slum population: (A) SS1 (B) SS2 (C) SS3 (D) SS4 (E) SS5 (F) 
SS6(G) SS7 (H) SS8 (I) SS9 (J) SS10 
The following figure is a graphical representation of serum activity against S. flexneri in 10 
representative samples of the slum population. 
Figure 3.12: Graphical representation of serum activity against S. flexneri at 0 minute and 180 
minutes in slum population 
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In order to compare the results, the average serum activity against S. flexneri  in different areas 
were calculated at 0 minute and 180 minutes and depicted in a graph. 
 
 
 
 
 
 
 
Figure 3.13: Graphical analysis of average serum activity against S. flexneri at 0 minute and 180 
minutes in different areas 
The percentage inhibition in growth of S. flexneri caused by serum samples collected from 
different areas was calculated for better understanding and comparison of the results.  
 
 
 
 
 
 
 
Figure 3.14: Graphical representation of percentage inhibition in growth of S. flexneri caused by 
serum collected from different areas
Discussion & Conclusion   Page 45 
 
4. DISCUSSION AND CONCLUSION 
Shigella flexneri is a Gram-negative bacterium and a human intestinal pathogen, causing the 
diarrhoeal disease shigellosis [Saeed et al., 2012]. Shigellosis is a disease which is recognized as 
a global problem with high morbidity and mortality, particularly in developing countries. It is 
highly endemic in Bangladesh, and occasionally flares into epidemics [Hossain et al., 1990]. S. 
flexneri is the predominant serotype of Shigella in Bangladesh [Islam et al., 1996]. Shigella is 
transmitted efficiently via the fecal-oral route [Weissman et al., 1975] and through the 
contamination of food [Marler, 2013]. The symptoms of shigellosis can range from mild 
diarrhoea to severe dysentery with the passage of frequent bloody, mucoid stools; other 
symptoms include fever, intestinal cramps and convulsions [Lonnen, 2007]. 
Human serum is considered an important host defence mechanism against invasive diseases 
caused by gram negative bacteria [Igumbor & Osayande, 2000]. It provides the host with 
antibodies and complement [Okamura et al., 1988]. The major role of the complement system is 
to recognize and promote the clearance of invading microorganisms [Bugla-Ploskonska et al., 
2009]. This involves a number of mechanisms including cell-independent bactericidal activity 
with formation of membrane attack complex, and opsonization for uptake and killing by 
phagocytic cells [O’Shaughnessy et al., 2012]. The complement mediated activity of serum 
might differ in different population groups. Therefore it is important to further investigate this 
activity and learn more about it. 
This study is reporting the comparative complement activity of blood serum against Shigella 
flexneri in urban and slum population. The two population groups are considered due to their 
significant differences in lifestyle. The slum based population live in overcrowded condition and 
often lack access to basic sanitation and safe drinking water. This might cause them to have a 
high exposure to the pathogen S. flexneri and exhibit higher resistance against it compared to the 
urban population.  
The results obtained showed that serum samples collected from both urban and slum based 
population is able to decrease and inhibit the growth of S. flexneri. The serum activity against 
S.flexneri at 0 minutes and 180 minutes for 10 representative serum samples collected from 
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urban area and slum area shown in figures. Each sample, from both areas, demonstrates a 
significant decrease in growth of S. flexneri from 0 minute to 180 minutes.  
In order to compare the complement activity of serum collected from the different population 
against S.flexneri, the average serum activity was determined. It was observed that the growth of 
S. flexneri at both 0 minute and 180 minutes was higher for serum samples collected from urban 
area compared to that collected from slum area. The percentage inhibition in growth of S. 
flexneri caused by serum samples collected from these different populations was then assessed. It 
clearly showed that serum collected from the slum population caused higher inhibition of S. 
flexneri in contrast to that collected from urban population.   
The results of the study help us to draw the conclusion that the urban population has a better 
lifestyle in terms of living condition, sanitation, safe drinking water etc. They do not have high 
exposure to a pathogen like S. flexneri, which is not a normal microbial flora of the human body 
like E. coli, and the serum collected from them is unable to inhibit growth of S. flexneri as 
effectively as slum population. The slum population, on the other hand, has repeated exposure to 
this pathogen and their serum can inhibit its growth more efficiently and exhibit resistance 
against it.  
Further studies are required using diverse population groups to compare the complement activity 
of serum against S.flexneri and find whether lifestyle changes cause any significant difference or 
not. 
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APPENDICES 
APPENDIX-I 
Media composition 
The composition of the media used in the present study has been given below. Unless 
otherwise mentioned, all the media were autoclaved at 121oC for 15 min 
1. Nutrient Agar (Himedia, India) 
Ingredients Amounts (g/L) 
Peptic Digest of Animal Tissue 5.0 
Beef Extract 1.50 
Sodium Chloride 5.0 
Yeast Extract 1.50 
Agar 15.0 
 
2. Nutrient Broth (Oxoid, England) 
Ingredients Amounts (g/L) 
Lab-lemco Powder 1.0 
Yeast extract 2.0 
Peptone 5.0 
Sodium Chloride 5.0 
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3. T1N1 Soft Agar 
Ingredients Amounts (g/L) 
Tryptone 0.6 
Sodium Chloride 0.3 
Agar 0.42 
 
4. Simmon’s Citrate Agar (Oxoid, England) 
Ingredients Amounts (g/L) 
Magnesium Sulfate 0.2 
Ammonium dihydrogen phosphate 0.2 
Ammonium phosphate 0.8 
Sodium citrate 2.0 
Sodium chloride 5.0 
Agar 15.0 
Bacto brom thymol blue 0.08 
 
5. Peptone Water 
Ingredients Amounts (g/L) 
Peptone 10.0 
Sodium Chloride 5.0 
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6. MR-VP broth 
Ingredients Amount (g/L) 
Peptone 7.0 
Dextrose 5.0 
Potassium Phosphate 5.0 
 
7. XLD (Xylose-Lysine-Deoxycholate) Agar (Himedia, India) 
Ingredients Amounts (g/L) 
L-lysine 5.0 
Lactose 7.50 
Sucrose 7.50 
Xylose 3.50 
Sodium chloride 5.0 
Sodium deoxycholate 2.50 
Yeast extract 3.0 
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APPENDIX-II 
Buffers and Reagents 
 
1. Kovac’s Reagent 
5 g of para-dimethylaminobenzaldehyde was dissolved in 75 ml of amyl alcohol. Then 
concentrated HCl was added to make the final volume 25 ml. This reagent was covered with 
aluminum foil and stored at 4oC. 
 
2. Methyl-red Reagent 
0.1 g of methyl red was dissolved in 300 ml of 95% ethyl alcohol. Then distilled water was 
added to make the final volume 500 ml. This reagent was covered with aluminum foil and 
stored at 4oC. 
 
3. Barritt’s Reagent 
Solution A 
5 g of alpha-naphthol was dissolved in 95% ethanol. This solution was covered with 
aluminum foil and stored at 4oC. 
Solution B 
40 g of KOH was dissolved in distilled water. The solution became warm. After cooling to 
room temperature, creatine was dissolved by stirring. Distilled water was added. This 
solution was covered with aluminum foil and stored at 4oC. 
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APPENDIX-III 
Instruments 
The important equipments used through the study are listed below: 
Name of Item Specification 
Autoclave Model: HL-340, Gemmy Industrial cor., 
Taiwan 
Balance Radwag, WTB200 
Centrifuge (High-speed refrigerated Micro 
centrifuge) 
Model: GAM 1.5-2.4 Scanspeed 1730, 
Denmark 
Hot Air Oven (Sterilizer) Model: 02G Jero Tech, Korea 
Incubator Model: DSI500, Taiwan 
Laminar airflow cabinet SAARC 
Micropipette (2-20µl) Eppendorf, Germany 
Micropipette (2-200µl) Eppendorf, Germany 
Micropipette (100-1000µl) Eppendorf, Germany 
Oven (Microwave Oven) Model: MH6548SR, LG, China 
Refrigerator Model-0636, Samsung 
Shaking Incubator Model: WIS-20R, Daihan Scientific, Korea 
Vortex Mixture VM-2000, digisystem, Taiwan 
 
 
